470 related articles for article (PubMed ID: 17049141)
1. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
2. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
3. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
[TBL] [Abstract][Full Text] [Related]
5. Blood conservation strategies to minimize allogeneic blood use in urologic surgery.
Monk TG; Goodnough LT
Am J Surg; 1995 Dec; 170(6A Suppl):69S-73S. PubMed ID: 8546252
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion.
Carless PA; Anthony DM; Henry DA
Br J Surg; 2002 Jun; 89(6):695-703. PubMed ID: 12027978
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Comparative Study of Different Methods of Blood Management in Total Knee Replacement.
Pappa E; Vergados N; Spiridakis E; Chountas G; Apostolopoulou A; Sourmelis S
J Knee Surg; 2019 Oct; 32(10):995-1000. PubMed ID: 30423590
[TBL] [Abstract][Full Text] [Related]
10. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.
Carless PA; Henry DA; Anthony DM
Cochrane Database Syst Rev; 2003; 2003(2):CD004171. PubMed ID: 12804501
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
12. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of epoetin and autologous blood donationin reducing allogeneic blood transfusions incoronary artery bypass graft surgery.
Marchetti M; Barosi G
Transfusion; 2000 Jun; 40(6):673-81. PubMed ID: 10864987
[TBL] [Abstract][Full Text] [Related]
14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.
McNicol ED; Tzortzopoulou A; Schumann R; Carr DB; Kalra A
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006883. PubMed ID: 27643712
[TBL] [Abstract][Full Text] [Related]
18. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'connell DL; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2006 Oct; (4):CD001888. PubMed ID: 17054147
[TBL] [Abstract][Full Text] [Related]
19. Cell salvage for minimising perioperative allogeneic blood transfusion.
Carless PA; Henry DA; Moxey AJ; O'Connell D; Brown T; Fergusson DA
Cochrane Database Syst Rev; 2010 Mar; (3):CD001888. PubMed ID: 20238316
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
